Annual ROE
-43.17%
+5.05%+10.47%
31 December 2023
Summary:
Editas Medicine annual return on equity is currently -43.17%, with the most recent change of +5.05% (+10.47%) on 31 December 2023. During the last 3 years, it has fallen by -7.81% (-22.09%). EDIT annual ROE is now -148.24% below its all-time high of 89.49%, reached on 31 December 2014.EDIT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-74.59%
-15.46%-26.15%
30 September 2024
Summary:
Editas Medicine quarterly return on equity is currently -74.59%, with the most recent change of -15.46% (-26.15%) on 30 September 2024. Over the past year, it has dropped by -21.96% (-41.73%). EDIT quarterly ROE is now -119.57% below its all-time high of 381.07%, reached on 30 June 2015.EDIT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | -41.7% |
| 3 y3 years | -22.1% | -86.7% |
| 5 y5 years | +12.8% | -33.2% |
EDIT ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.1% | +10.5% | -132.6% | at low |
| 5 y | 5 years | -22.1% | +19.5% | -157.5% | at low |
| alltime | all time | -148.2% | +88.6% | -119.6% | +77.2% |
Editas Medicine ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -74.59%(+26.1%) |
| June 2024 | - | -59.13%(+22.5%) |
| Mar 2024 | - | -48.26%(+12.6%) |
| Dec 2023 | -43.17%(-10.5%) | -42.86%(-18.6%) |
| Sept 2023 | - | -52.63%(+0.2%) |
| June 2023 | - | -52.54%(-0.6%) |
| Mar 2023 | - | -52.86%(+10.7%) |
| Dec 2022 | -48.22%(+18.6%) | -47.77%(+20.3%) |
| Sept 2022 | - | -39.70%(+17.6%) |
| June 2022 | - | -33.76%(+5.3%) |
| Mar 2022 | - | -32.07%(-7.2%) |
| Dec 2021 | -40.65%(+15.0%) | -34.56%(-13.5%) |
| Sept 2021 | - | -39.95%(+20.5%) |
| June 2021 | - | -33.16%(+4.8%) |
| Mar 2021 | - | -31.63%(-4.1%) |
| Dec 2020 | -35.36%(-34.1%) | -32.98%(+13.8%) |
| Sept 2020 | - | -28.97%(-41.8%) |
| June 2020 | - | -49.75%(-21.8%) |
| Mar 2020 | - | -63.65%(+6.5%) |
| Dec 2019 | -53.65% | -59.77%(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -55.99%(+19.5%) |
| June 2019 | - | -46.87%(+0.1%) |
| Mar 2019 | - | -46.80%(-2.3%) |
| Dec 2018 | -49.50%(-29.5%) | -47.91%(-13.8%) |
| Sept 2018 | - | -55.59%(-11.9%) |
| June 2018 | - | -63.09%(+7.6%) |
| Mar 2018 | - | -58.63%(-11.1%) |
| Dec 2017 | -70.22%(-81.4%) | -65.97%(-6.6%) |
| Sept 2017 | - | -70.66%(+5.9%) |
| June 2017 | - | -66.74%(+8.7%) |
| Mar 2017 | - | -61.41%(-22.9%) |
| Dec 2016 | -377.46%(-530.4%) | -79.61%(+36.4%) |
| Sept 2016 | - | -58.37%(-14.1%) |
| June 2016 | - | -67.99%(-54.1%) |
| Mar 2016 | - | -148.07%(-54.8%) |
| Dec 2015 | 87.71%(-2.0%) | -327.63%(+180.2%) |
| Sept 2015 | - | -116.94%(-130.7%) |
| June 2015 | - | 381.07%(+444.5%) |
| Mar 2015 | - | 69.98%(+97.8%) |
| Dec 2014 | 89.49% | 35.38% |
FAQ
- What is Editas Medicine annual return on equity?
- What is the all time high annual ROE for Editas Medicine?
- What is Editas Medicine annual ROE year-on-year change?
- What is Editas Medicine quarterly return on equity?
- What is the all time high quarterly ROE for Editas Medicine?
- What is Editas Medicine quarterly ROE year-on-year change?
What is Editas Medicine annual return on equity?
The current annual ROE of EDIT is -43.17%
What is the all time high annual ROE for Editas Medicine?
Editas Medicine all-time high annual return on equity is 89.49%
What is Editas Medicine annual ROE year-on-year change?
Over the past year, EDIT annual return on equity has changed by +5.05% (+10.47%)
What is Editas Medicine quarterly return on equity?
The current quarterly ROE of EDIT is -74.59%
What is the all time high quarterly ROE for Editas Medicine?
Editas Medicine all-time high quarterly return on equity is 381.07%
What is Editas Medicine quarterly ROE year-on-year change?
Over the past year, EDIT quarterly return on equity has changed by -21.96% (-41.73%)